WatanabeCrc PressA general view of large bowel cancer in Japan. Watanabe, S, Tominaga, S, Kakizoe, T eds. (1995) Cancer treatment and survival: site-specific registries in Japan. Japan Scientific Societies Press, Tokyo, pp. 57-67
Objectives Analyzing the cancer treatment situation in Japan is an important public health issue, especially because of increasing crude cancer morbidity in a rapidly aging society. This study aimed to examine where cancer patients received treatment, with special attention to designated regional cancer...
e20070#Background:In Japan, lung cancer has high incidence and mortality among all cancers. The study is to understand the existing status of the treatment modalities in Japan, especially for radiotherapy (RT).Methods:This was a retrospective cohort study using the Japan Medical Data Center (JMDC...
The drug was first approved for use in Japan in March and will be the country's first cancer treatment involving CAR-T cell therapy, which works by genetically modifying a patient's own immune system T-cells to boost their ability to fight the disease. The drug that has already been appro...
Concern regarding the economic aspect of cancer care has been increasing in the face of mounting healthcare expenditure in Japan. The need, not only for effective, but also for efficient treatment options in breast cancer care have been recognized in a broader context. In clinical practice, treat...
The sixth edition of the Japanese Gastric Cancer Treatment Guidelines was completed in July 2021, incorporating new evidence that emerged after publication
Significant superiority over, or non-inferiority to, the conventional standard treatment in terms of overall survival has been proven by a domestic or international phase III clinical trial. Reproducible clinical benefit has been demonstrated by multiple domestic or international phase II clinical trials ...
In Japan, BNCT has been approved for the treatment of unresectable advanced or recurrent head and neck tumours, explains Koji Ono, director of the Kansai BNCT Medical Center at Osaka Medical and Pharmaceutical University. Standard treatments, such as chemotherapy, other radiotherapies or targeted phar...
Over the last decade, patient involvement in treatment-related decision-making has been widely advocated in Japan, where patient-physician encounters are still under the influence of the long-standing tradition of paternalism. Despite this profound change in clinical practice, studies investigating the ...
A prospective trial of the tnm classification of breast cancer by the regional cancer treatment centres in Ontario, 1960–1964 As its contribution to the 1960鈥 64 clinical trial of the TNM Classification of breast cancer, The Ontario Cancer Treatment and Research Foundation reviewed in detail the...